Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Cools

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology|January 7, 2010
Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibitionMargery A Connelly, Tom J Parry, Edward C Giardino, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Open Heart|May 11, 2023
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registryPatricia Apenteng, Saverio Virdone, John Camm, et al.
Journal of the American College of Cardiology|September 18, 2020
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral AnticoagulantsAlan John Camm, Frank Cools, Saverio Virdone, et al.
European Heart Journal|December 28, 2017
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryFreek W A Verheugt, Haiyan Gao, Wael Al Mahmeed, et al.
American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.
The American Journal of Medicine|November 2, 2023
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistrySamuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, et al.
European Heart Journal|July 1, 2016
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AFJean-Pierre Bassand, Gabriele Accetta, Alan John Camm, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF RegistryFrank Cools, Dana Johnson, Alan J Camm, et al.
Blood Advances|February 19, 2021
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registryJean-Pierre Bassand, Saverio Virdone, Marc Badoz, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|January 7, 2010
Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibitionMargery A Connelly, Tom J Parry, Edward C Giardino, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Open Heart|May 11, 2023
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registryPatricia Apenteng, Saverio Virdone, John Camm, et al.
Journal of the American College of Cardiology|September 18, 2020
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral AnticoagulantsAlan John Camm, Frank Cools, Saverio Virdone, et al.
European Heart Journal|December 28, 2017
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryFreek W A Verheugt, Haiyan Gao, Wael Al Mahmeed, et al.
American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.
The American Journal of Medicine|November 2, 2023
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistrySamuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, et al.
European Heart Journal|July 1, 2016
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AFJean-Pierre Bassand, Gabriele Accetta, Alan John Camm, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF RegistryFrank Cools, Dana Johnson, Alan J Camm, et al.
Blood Advances|February 19, 2021
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registryJean-Pierre Bassand, Saverio Virdone, Marc Badoz, et al.
Pageof 4